Literature DB >> 23923282

Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome.

Tania Dickson-Humphries1, B Bottenberg, Susan Kuntz.   

Abstract

Cardiovascular disease remains the leading cause of death in men and women in the United States. Aggressive treatment of insulin resistance and its associated lipid abnormalities remains a top priority for preventing cardiovascular morbidity and mortality.

Entities:  

Mesh:

Year:  2013        PMID: 23923282     DOI: 10.1097/01.jaa.0000431506.00627.be

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  2 in total

1.  Improvement of continuous subcutaneous insulin infusion on patients with type 2 diabetes mellitus by 3-dimensional speckle tracking echocardiography.

Authors:  Hong-Xia Luo; Xiao-Ling Zhou; Hong-Ju Kou; Xian-Wei Ni; Qing Wu; Chun-Peng Zou; Dao-Zhu Wu; Yong-Fang Liu
Journal:  Int J Cardiovasc Imaging       Date:  2017-09-21       Impact factor: 2.357

2.  Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetes.

Authors:  Haihua Gu; Yongqiang Liu; Shuang Mei; Bingdi Wang; Guofeng Sun; Xiaoli Wang; Yongfu Xiao; Michael Staup; Francine M Gregoire; Keefe Chng; Yixin Jim Wang
Journal:  BMC Cardiovasc Disord       Date:  2015-10-30       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.